Categories: AnalyticsCareDataHealthTechIndustryMarketplaceMedtechPlatformResearch
Increasing your probability of success through the adoption of meaningful endpoints, starting from electrophysiology.
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 04.09.2024 | - | $5.54M | - |
Mentions in press and media 5
| Date | Title | Description |
| 20.11.2025 | Indivi Nets $16.8M for Alzheimer's Biomarker Discovery | Indivi secured CHF 15 million. This will boost Alzheimer's drug development. The company will launch a trial in 2026. It seeks better biomarkers. This aims to improve treatment efficacy. The funds will advance precision medicine. This targe... |
| 12.11.2025 | Indivi: CHF15 Million Secured To Advance Biomarker Discovery In Alzheimer’s Drug Development | Indivi, a Basel-based Tech Bio company specializing in precision medicine for neuroscience, announced the successful closing of a CHF 15 million investment round led by Ava Investors. The new funding will accelerate the validation and deplo... |
| 04.09.2024 | Clouds of Care Secures 5 Million Euros to Propel CNS Healthcare Innovation and appoints former CEO of Biogen, Michel Vounatsos, as chairman of the board of directors | GHENT, Belgium, Sept. 4, 2024 /PRNewswire/ -- Clouds of Care, a leading MedTech company dedicated to enabling better care for people with Central Nervous System (CNS) disorders, proudly announces the successful closure of its funding round.... |
| 04.09.2024 | Clouds of Care Raises €5M in Funding | The Clouds of Care management with from left to right: Eline Van Vlierberghe (CCO), Gregor Strobbe (co-founder, CEO), Pieter van Mierlo (co-founder, CSO), Jeroen Crappé (COO), Caroline Neuray (CMO), Tom Van Steenkiste (CTO)
Clouds of Care, ... |
| - | Clouds of care | “Clouds of care supports HealthTech companies on their journey from algorithm validation to medical device software.” |
Reviews 0
